Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides
about
Immunotoxicity of 2',3'-dideoxyinosine in female B6C3F1 miceNucleoside Oxidase, a Hydrogen Peroxide-Forming Oxidase, from Flavobacterium meningosepticum.Purification, characterization, and gene cloning of purine nucleosidase from Ochrobactrum anthropiInhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virusTherapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericinThe development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemicVisna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosidesMultidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapyAn Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodiesApproved Antiviral Drugs over the Past 50 Years2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcri(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitroGreatly enhanced inhibition of human immunodeficiency virus type 1 replication in CEM and HT4-6C cells by 3'-deoxythymidine diphosphate dimyristoylglycerol, a lipid prodrug of 3'-deoxythymidineComparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidineIn vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinationsThe separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitroIn vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitorsThe inhibition of human immunodeficiency virus type 1 reverse transcriptase by avarol and avarone derivativesIllimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptaseSynergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidineIn vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosineSynergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitroDidanosine therapy in patients intolerant of or failing zidovudine therapyAnti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analogCyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitroActivities of (-)-carbovir and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitroRibavirin antagonizes the effect of azidothymidine on HIV replicationSynergistic activity of granulocyte-macrophage colony-stimulating factor and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitroRegulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cellsPhosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitroSusceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidinePhosphorylation of 3'-azido-2',3'-dideoxyuridine and preferential inhibition of human and simian immunodeficiency virus reverse transcriptases by its 5'-triphosphateStructure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynuclHuman immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine aloneMechanism of action and in vitro activity of 1',3'-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variantsPolycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerasesInhibition of infectivity of human immunodeficiency virus by a novel nucleoside, oxetanocin, and related compoundsInhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides
P2860
Q23915942-CDED4588-22D4-4692-A186-516519FA872CQ24542513-0111BA98-7418-4DD0-9234-F5F0E2189A19Q24550164-B07C6F52-BA13-4B18-A8E7-E7E8A6920636Q24619823-333083E7-EE89-44FA-B49B-90BBF0B66EC5Q24652927-FA16AD0A-1DE6-4812-AD16-F25944BEE925Q24655011-996AF562-E548-48E9-A5E0-2DD55BA676EBQ24676814-F887F757-4728-42C4-A376-539D8C42E379Q24684152-6049DD4C-CE10-48B4-B2D3-141F24AAAB5FQ26771734-096C7C9D-AB9A-4FAA-94C4-D5E046481B19Q27485071-624DAEDC-8D24-47A2-9AE0-C85AE513EBB1Q27755387-B0F53814-A2B0-4771-BF93-8FD7C89A5CEFQ28316183-FFCD6D5D-9830-43A9-9E69-3C551BCD53CAQ28316326-1F97E765-67EF-486D-B61B-D1922C2B5CF7Q28316971-216C8592-AE72-4699-8E1D-419AB4D084B7Q28318354-99C4DFF6-33CC-4EC7-B166-CA21DB63EF41Q28318476-5D91736F-5A81-4A11-BA37-3837F6F7E034Q28319933-3DFDA611-4388-461E-A495-AC65B595F90AQ28323307-C6A3571F-69A5-475D-98A0-936183EBE3FAQ28323456-181CF423-90E9-4D5B-A0FC-F1EC533EB5A0Q28323712-D63AC9C8-2180-42B0-9F8B-1A1D1151D4FFQ28324208-A895D359-0427-4BFE-A937-23039B1A8ADDQ28324338-0CAFB13C-824D-4708-8684-5B48BA9D0A0BQ28326720-46FC496A-7824-4288-9B4A-3BAD02E7916AQ28327854-DB8754CE-CB72-409C-8898-A2322E2522B5Q28333679-5377D430-DC12-40A4-812B-C40E3590243FQ28334680-4D641738-CC0D-40FC-8E01-64CAA664CF2EQ28335926-6578CBE5-2364-4405-91DF-E7E186E903D6Q28337829-18FCF8ED-6BFB-4AF8-9853-359C3CB0B4DEQ28338307-7FDB8FE1-826B-4796-B0AC-DF9847FDE1C7Q28339853-E694189B-B9AC-4CF7-AB87-A7121BF24501Q28340188-C1A12597-9701-4621-9B06-3B5F48C27FB7Q28340298-07F0CB23-40BD-43F5-AB53-18113A8644B7Q28340356-4D4685D8-5809-4CD3-AED1-905ADF74D1D2Q28342189-067794E6-9CF7-4E67-B3DE-A1CF24691A60Q28342341-A4AEF637-DBDC-477C-BD4A-28F61A7F05A9Q28342825-58E7CA2E-D152-4308-89F8-672369DB3AFAQ28343606-E4CA1B2D-56AF-4003-830D-A9111BEF1370Q28343672-2EEB812C-ADC9-439A-B176-E85180D07531Q28359652-4B689B19-3D03-4BA0-BA77-71033D4A91B4Q28359853-41BE4AA6-F0F1-4635-A7E2-02F02E49FFF2
P2860
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides
description
1986 nî lūn-bûn
@nan
1986 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի մարտին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Inhibition of the in vitro inf ...... V) by 2',3'-dideoxynucleosides
@ast
Inhibition of the in vitro inf ...... V) by 2',3'-dideoxynucleosides
@en
Inhibition of the in vitro inf ...... V) by 2',3'-dideoxynucleosides
@nl
type
label
Inhibition of the in vitro inf ...... V) by 2',3'-dideoxynucleosides
@ast
Inhibition of the in vitro inf ...... V) by 2',3'-dideoxynucleosides
@en
Inhibition of the in vitro inf ...... V) by 2',3'-dideoxynucleosides
@nl
prefLabel
Inhibition of the in vitro inf ...... V) by 2',3'-dideoxynucleosides
@ast
Inhibition of the in vitro inf ...... V) by 2',3'-dideoxynucleosides
@en
Inhibition of the in vitro inf ...... V) by 2',3'-dideoxynucleosides
@nl
P2860
P356
P1476
Inhibition of the in vitro inf ...... V) by 2',3'-dideoxynucleosides
@en
P2093
P2860
P304
P356
10.1073/PNAS.83.6.1911
P407
P577
1986-03-01T00:00:00Z